<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-TRYX277M/1981e026-1eba-44d9-87fa-6693a38bf900/PDF"><dcterms:extent>406 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-TRYX277M/f50de9e7-4ee3-4d49-b042-b731c73496f6/TEXT"><dcterms:extent>18 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1992-2025"><edm:begin xml:lang="en">1992</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-TRYX277M"><edm:isNextInSequence rdf:resource="https://www.dlib.si/details/URN:NBN:SI:doc-O1WKL7WF" /><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-FNIFVE9S" /><dcterms:issued>1999</dcterms:issued><dc:creator>Kansky, Aleksej</dc:creator><dc:format xml:lang="sl">letnik:33</dc:format><dc:format xml:lang="sl">str. S69-S74</dc:format><dc:format xml:lang="sl">številka:suppl. 1</dc:format><dc:identifier>COBISSID:10734553</dc:identifier><dc:identifier>ISSN:1318-2099</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-TRYX277M</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Croatian Medical Association - Croatian Society of Radiology</dc:publisher><dc:publisher xml:lang="sl">Slovenian Medical Society - Section of Radiology</dc:publisher><dcterms:isPartOf xml:lang="sl">Radiology and oncology (Ljubljana)</dcterms:isPartOf><dc:subject xml:lang="sl">Adverse effects</dc:subject><dc:subject xml:lang="sl">etiologija</dc:subject><dc:subject xml:lang="sl">Etiology</dc:subject><dc:subject xml:lang="sl">karcinogeneza</dc:subject><dc:subject xml:lang="sl">kožne spremembe</dc:subject><dc:subject xml:lang="sl">novotvorbe</dc:subject><dc:subject xml:lang="sl">onkologija</dc:subject><dc:subject xml:lang="sl">Skin neoplasms</dc:subject><dc:subject xml:lang="sl">škodljivost</dc:subject><dc:subject xml:lang="sl">ultravijolično sevanje</dc:subject><dc:subject xml:lang="sl">Ultraviolet rays</dc:subject><dcterms:temporal rdf:resource="1992-2025" /><dc:title xml:lang="sl">Fotokarcinogeneza| Photocarcinogenesis|</dc:title><dc:description xml:lang="sl">Photocarcinogenesis is a complex and still not fully explored process. Epidemiological studies as well as animal experiments show that wave lenghts in the range of 320-280 nm (UV B) are the main pathogenetic factor. Skin complexion and other genetic factors are however also important. The UV B raysare injuring directly the molecules of deoxyribonucleic acidic in the nuclei keratinocytes, fibroblast and Langerhans; cells, but the inducement of various molecules (chromatophores) into an excited stage is a further pathogenetic mechanism. This situation lasts only fraction of a ssecond and the relase of various forms of energy, which follows, is injuring cells and their organel as well as producing noxious products, e.g., pereoxides. In the inducement of carcinogenesis further mechanisms are usually coivolved as an impaired action of repartion enzmes, immunosuppression of T lymphocytes by UV B, expression of oncogenes and antiocogenes and others. A short review of th eabove mentioned processes is given</dc:description><dc:description xml:lang="sl">Fotokarcinogeneza je zapleten in kompleksen proces. Epidemiološke študije in poskusi na živalih kažejo, da je najpomembnejši činitelj ultravijolična (UV) svetloba z valovno dolžino med 320 in 280 nm. UV žarki lahko okvarjajo neposredno molekule deoksiribonukleinske kisline (DNK) v jedrih celic, pomembnejša pa je aktivacija različnih molekul, ki prehajajo v ekscitirano stanje ter se nato spojijo z DNK v fotoadukte. Ekscitirano stanje traja le delce sekunde, ko preneha, se sproščajo različne oblike energije, pri čemer prihaja do okvare celic in njihovih organel, kakor tudi do nastanka različnih škodljivih spojin kot so npr. peroksidi. Za nastanek kožnih karcinomov so pomembni še nekateri drugi procesi: moteno delovanje reparacijskih encimov, imunosupresijski učinek UV svetlobe na limfocite T, akkor tudi aktivnost onkogenov in antionkogenov. Pri vseh naštetih procesih sodeluje tudi dednost, saj vpliva med drugim na občutlivost kože za svetlobo, na reparacijske encime,na občutljivost limfocitov na svetlobo ter na delovanje onkogenov</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-TRYX277M"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-TRYX277M" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-TRYX277M/1981e026-1eba-44d9-87fa-6693a38bf900/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Onkološki inštitut Ljubljana</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-TRYX277M/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-TRYX277M" /></ore:Aggregation></rdf:RDF>